Observational Study of RHINOSEDAL in Acute Nasal Obstruction
NCT: NCT07620522 · NOT_YET_RECRUITING
Brief Summary
This prospective, multicenter, national, observational, non-interventional post-market clinical follow-up study evaluates the performance and safety of RHINOSEDAL in children and adults presenting with acute nasal obstruction associated with common cold, allergic or non-allergic rhinitis, or rhinosinusitis. Patients prescribed RHINOSEDAL in routine care will be followed for 6 ±1 days using patient-reported outcome measures including the NOSE score.
Frequently Asked Questions
What is Observational Study of RHINOSEDAL in Acute Nasal Obstruction?
Observational Study of RHINOSEDAL in Acute Nasal Obstruction is a clinical trial registered under NCT07620522. Current status: NOT_YET_RECRUITING.
What is the status of NCT07620522?
The current status of NCT07620522 (Observational Study of RHINOSEDAL in Acute Nasal Obstruction) is: NOT_YET_RECRUITING.
When did Observational Study of RHINOSEDAL in Acute Nasal Obstruction start?
Observational Study of RHINOSEDAL in Acute Nasal Obstruction started on 2026-10-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.